RAPT Therapeutics to Participate in Upcoming Investor Conferences
Goldman Sachs 46th Annual Global Healthcare Conference – Fireside chat on Tuesday, June 10, 2025 at 9:20 a.m. ET
UBS Spring Biotech Conference – Investor one-on-one meetings on Tuesday, June 24, 2025
To access the live webcast or subsequent archived recording of the Goldman Sachs fireside chat, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.
About RAPT Therapeutics, Inc.
RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases. Utilizing our deep and proprietary expertise in immunology, we develop novel therapies that are designed to modulate the critical immune responses underlying these diseases.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
3 minutes ago
- Wall Street Journal
Heard on the Street Monday Recap: Atlantic Divide
Stocks held firm as earnings season continued. Both the S&P 500 and the Nasdaq Composite hit new record highs, with the S&P adding 0.1% and the Nasdaq gaining 0.4%. The Dow Jones Industrial Average shed 19 points. Tariff negotiations continued. The European Union is still striving for a deal, but a baseline U.S. tariff of 15% or more appears too high for EU negotiators. The bloc is readying retaliatory measures if that rate can't be lowered further in talks. Verizon shares jumped. The telecommunications giant raised its annual earnings forecast, and its shares rallied 4%, leading the S&P.
Business Insider
30 minutes ago
- Business Insider
RBC Capital Keeps Their Hold Rating on Check Point (CHKP)
RBC Capital analyst Matthew Hedberg maintained a Hold rating on Check Point yesterday and set a price target of $224.00. The company's shares closed yesterday at $222.64. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Hedberg is a top 100 analyst with an average return of 21.8% and a 70.00% success rate. Hedberg covers the Technology sector, focusing on stocks such as Gitlab, ServiceNow, and Snowflake. In addition to RBC Capital, Check Point also received a Hold from Cantor Fitzgerald's Jonathan Ruykhaver in a report issued yesterday. However, on the same day, Wells Fargo maintained a Buy rating on Check Point (NASDAQ: CHKP). The company has a one-year high of $234.36 and a one-year low of $169.02. Currently, Check Point has an average volume of 766.1K.
Business Insider
30 minutes ago
- Business Insider
RBC Capital Reaffirms Their Hold Rating on CommVault Systems (CVLT)
In a report released yesterday, Dan Bergstrom from RBC Capital maintained a Hold rating on CommVault Systems, with a price target of $185.00. The company's shares closed yesterday at $168.73. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Bergstrom is a 4-star analyst with an average return of 11.8% and a 57.89% success rate. Bergstrom covers the Technology sector, focusing on stocks such as CommVault Systems, CSG Systems International, and Fortinet. In addition to RBC Capital, CommVault Systems also received a Hold from Piper Sandler's James Fish in a report issued on July 14. However, on July 18, TR | OpenAI – 4o reiterated a Buy rating on CommVault Systems (NASDAQ: CVLT). Based on CommVault Systems' latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $275.04 million and a net profit of $30.99 million. In comparison, last year the company earned a revenue of $223.29 million and had a net profit of $126.12 million Based on the recent corporate insider activity of 41 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CVLT in relation to earlier this year. Most recently, in May 2025, Sanjay Mirchandani, the President & CEO of CVLT sold 1,709.00 shares for a total of $299,075.00.
